Vales A - Search Results

1

Linkage of alterations in systemic iron homeostasis to patients' outcome in sepsis: a prospective study.

Brandtner A, Tymoszuk P, Nairz M, Lehner GF, Fritsche G, Vales A, Falkner A, Schennach H, Theurl I, Joannidis M, Weiss G, Pfeifhofer-Obermair C. Brandtner A, et al. Among authors: vales a. J Intensive Care. 2020 Oct 1;8:76. doi: 10.1186/s40560-020-00495-8. eCollection 2020. J Intensive Care. 2020. PMID: 33014378 Free PMC article.

2

Novel KEL*02M allele in Austria encoding a K_mod phenotype.

Polin H, Dal-Pont C, Schennach H, Vales A, Steitzer H, Danzer M. Polin H, et al. Among authors: vales a. Transfusion. 2022 Feb;62(2):E8-E9. doi: 10.1111/trf.16764. Epub 2021 Dec 15. Transfusion. 2022. PMID: 34910313 No abstract available.

3

Prevalence of SARS-CoV-2 antibodies in healthy blood donors from the state of Tyrol, Austria, in summer 2020.

Siller A, Wachter GA, Neururer S, Pfeifer B, Astl M, Borena W, Kimpel J, Elmer S, Spöck F, Vales A, Mühlbacher A, Gaber M, Willeit P, Schennach H. Siller A, et al. Among authors: vales a. Wien Klin Wochenschr. 2021 Dec;133(23-24):1272-1280. doi: 10.1007/s00508-021-01963-3. Epub 2021 Oct 26. Wien Klin Wochenschr. 2021. PMID: 34698961 Free PMC article.

4

Prognostic significance of serial determinations of lactate dehydrogenase (LDH) in the follow-up of patients with myelodysplastic syndromes.

Wimazal F, Sperr WR, Kundi M, Vales A, Fonatsch C, Thalhammer-Scherrer R, Schwarzinger I, Valent P. Wimazal F, et al. Among authors: vales a. Ann Oncol. 2008 May;19(5):970-6. doi: 10.1093/annonc/mdm595. Epub 2008 Feb 13. Ann Oncol. 2008. PMID: 18272915 Free article.

5

Targeting of mTOR is associated with decreased growth and decreased VEGF expression in acute myeloid leukaemia cells.

Böhm A, Aichberger KJ, Mayerhofer M, Herrmann H, Florian S, Krauth MT, Derdak S, Samorapoompichit P, Sonneck K, Vales A, Gleixner KV, Pickl WF, Sperr WR, Valent P. Böhm A, et al. Among authors: vales a. Eur J Clin Invest. 2009 May;39(5):395-405. doi: 10.1111/j.1365-2362.2009.02101.x. Eur J Clin Invest. 2009. PMID: 19320940

6

Evaluation of antileukaemic effects of rapamycin in patients with imatinib-resistant chronic myeloid leukaemia.

Sillaber C, Mayerhofer M, Böhm A, Vales A, Gruze A, Aichberger KJ, Esterbauer H, Pfeilstöcker M, Sperr WR, Pickl WF, Haas OA, Valent P. Sillaber C, et al. Among authors: vales a. Eur J Clin Invest. 2008 Jan;38(1):43-52. doi: 10.1111/j.1365-2362.2007.01892.x. Eur J Clin Invest. 2008. PMID: 18173550 Clinical Trial.

7

CD203c is overexpressed on neoplastic mast cells in systemic mastocytosis and is upregulated upon IgE receptor cross-linking.

Hauswirth AW, Escribano L, Prados A, Nuñez R, Mirkina I, Kneidinger M, Florian S, Sonneck K, Vales A, Schernthaner GH, Sanchez-Muñoz L, Sperr WR, Bühring HJ, Orfao A, Valent P. Hauswirth AW, et al. Among authors: vales a. Int J Immunopathol Pharmacol. 2008 Oct-Dec;21(4):797-806. doi: 10.1177/039463200802100404. Int J Immunopathol Pharmacol. 2008. PMID: 19144265 Free article.

8

The effects of dasatinib on IgE receptor-dependent activation and histamine release in human basophils.

Kneidinger M, Schmidt U, Rix U, Gleixner KV, Vales A, Baumgartner C, Lupinek C, Weghofer M, Bennett KL, Herrmann H, Schebesta A, Thomas WR, Vrtala S, Valenta R, Lee FY, Ellmeier W, Superti-Furga G, Valent P. Kneidinger M, et al. Among authors: vales a. Blood. 2008 Mar 15;111(6):3097-107. doi: 10.1182/blood-2007-08-104372. Epub 2008 Jan 7. Blood. 2008. PMID: 18180381 Free article.

9

Interleukin-13 promoter gene polymorphism -1112C/T is associated with the systemic form of mastocytosis.

Nedoszytko B, Niedoszytko M, Lange M, van Doormaal J, Gleń J, Zabłotna M, Renke J, Vales A, Buljubasic F, Jassem E, Roszkiewicz J, Valent P. Nedoszytko B, et al. Among authors: vales a. Allergy. 2009 Feb;64(2):287-94. doi: 10.1111/j.1398-9995.2008.01827.x. Allergy. 2009. PMID: 19178408

10

Low-level expression of proapoptotic Bcl-2-interacting mediator in leukemic cells in patients with chronic myeloid leukemia: role of BCR/ABL, characterization of underlying signaling pathways, and reexpression by novel pharmacologic compounds.

Aichberger KJ, Mayerhofer M, Krauth MT, Vales A, Kondo R, Derdak S, Pickl WF, Selzer E, Deininger M, Druker BJ, Sillaber C, Esterbauer H, Valent P. Aichberger KJ, et al. Among authors: vales a. Cancer Res. 2005 Oct 15;65(20):9436-44. doi: 10.1158/0008-5472.CAN-05-0972. Cancer Res. 2005. PMID: 16230407

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

63 results

Search Page